Jas Gill serves as the Managing Director of Delmedica Investments Ltd, where he leverages his entrepreneurial spirit and strategic acumen to spearhead innovative solutions in the healthcare technology sector. With a robust background in both market-leading PLCs and start-ups, Jas has cultivated a unique expertise...
Jas Gill serves as the Managing Director of Delmedica Investments Ltd, where he leverages his entrepreneurial spirit and strategic acumen to spearhead innovative solutions in the healthcare technology sector. With a robust background in both market-leading PLCs and start-ups, Jas has cultivated a unique expertise in driving profitable revenue growth and fostering B2B/B2P innovation management. His current role involves not only overseeing the P&L but also leading the charge in research and development (R&D) and product commercialization, particularly in the respiratory space.
Under his leadership, Delmedica has successfully identified and developed groundbreaking innovations that are transforming patient care. One of his key projects includes the creation of a digital platform designed for home healthcare, which enhances patient engagement and streamlines clinical workflows. This initiative has attracted significant interest from investors, culminating in the successful securing of multi-million dollar funding and intellectual property (IP) rights, positioning the company at the forefront of global biotechnologies.
Jas’s commitment to sustainability and capability improvement is evident in his approach to relationship management, where he actively collaborates with clients, stakeholders, academics, and clinical professionals. His ability to build and lead international teams has been instrumental in navigating the complexities of clinical trials and business development, ensuring that Delmedica remains agile and responsive to market demands. With a clear vision for the future, Jas continues to drive innovation in medical devices, making a lasting impact on the healthcare landscape.
